Effect of the HMG-CoA Reductase Inhibitors on Blood Pressure in Patients With Essential Hypertension and Primary Hypercholesterolemia

This publication has 20 references indexed in Scilit:

• Raised plasma endothelin-I concentration following cold pressor test
  Published by Elsevier ,2004
• Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin
  Atherosclerosis, 1997
• The effects of nitric oxide (NO) on platelet membrane receptor expression during activation with human ??-thrombin
  Blood Coagulation & Fibrinolysis, 1996
• Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men
  The American Journal of Cardiology, 1996
• Impaired Endothelium-Dependent Vasodilation of Coronary Resistance Vessels in Hypercholesterolemic Patients.
  Internal Medicine, 1996
• Design, rationale, and baseline characteristics of the Prospective Pravastatin Pooling (PPP) project—A combined analysis of three large-scale randomized trials: Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID), Cholesterol and Recurrent Events (CARE), and West of Scotland Coronary Prevention Study (WOSCOPS)
  The American Journal of Cardiology, 1995
• Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolemia and systemic hypertension
  The American Journal of Cardiology, 1995
• Short Term Effects of Pravastatin on Blood Pressure in Hypercholesterolaemic Hypertensive Patients
  Blood Pressure, 1994
• Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension.
  Journal of Clinical Investigation, 1993
• Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension
  The American Journal of Cardiology, 1993